Effects of purified micronized flavonoid fraction (detralex®) on prophylactic treatment of adjuvant arthritis with methotrexate in rats

Israel Medical Association Journal

Volumn 10, Issue 5, 2008, Pages 377-380

  Rovenský, Jozef ^a,c   Švík, Karol ^a   Rovenská, Emília ^a   Štvrtinová, Viera ^b   Stančíková, Mária ^a  

^a NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c NONE   (Slovakia)

Author keywords

Adjuvant arthritis; Detralex; Methotrexate; Microcirculation; Purified micronized flavonoid fraction

Indexed keywords

ALBUMIN; DETRALEX; FLAVONOID; METHOTREXATE; NITRATE; NITRITE; PURIFIED MICRONIZED FLAVONOID FRACTION; SODIUM CHLORIDE;

ADJUVANT ARTHRITIS; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHROGRAPHY; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG POTENTIATION; LONG TERM CARE; LOW DRUG DOSE; MALE; MICROCIRCULATION; MONOTHERAPY; NONHUMAN; PAW EDEMA; PROTEIN BLOOD LEVEL; RAT; SCORING SYSTEM; TREATMENT DURATION;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; BONE DENSITY; DIOSMIN; DRUG COMBINATIONS; EDEMA; HESPERIDIN; MALE; METHOTREXATE; NITRATES; NITRITES; PLETHYSMOGRAPHY; RATS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX;

EID: 46149093709     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Lonchampt M, Guardiola B, Sicot N, Bertrand N, Perdrix L, Duhault J. Protective effect of a purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study. Arzneimittelforschung 1989;39:882-5.
2. Di Perri T, Auteri A. Action of S 5682 on the complement system. In vitro and in vivo study. Int Angiol 1988;7(Suppl 2):11-15.
3. Laurent R, Gilly R, Frileux C. Clinical evaluation of a venotropic drug in man. Int Angiol 1988;7(Suppl 2):39-43.
4. Földi M. Atlas of the Lymphatics of the Lower Limbs. Paris: Les Laboratoires Servier, 1999:s1-80.
5. Bollinger A, Herrig I, Fischer M, Hoffmann U, Franczeck UK. Intravital capillaroscopy in patients with chronic venous insuffuciency and lymphoedema: relevance to Daflon 500 mg. Int J Microcirc Clin Exp 1995;15(Suppl 1):41-4.
6. Labrid C. A lymphatic function of Daflon 500. Int Angiol 1995; 14(Suppl 1):36-8.
7. Cotonat A, Cotonat J. Lymphagogue and putsatile activities of Daflon 500 on canine throracic lymph duct. Int Angiol 1989 8(Suppl 4):15-18.
8. Takase S, Delano FA, Lerond L, Bergan JJ, Schmid-Schönbein GW. Inflammation in chronic venous insufficiency. Is the problem insurmountable? J Vasc Res 1999;36(Suppl 1):3-10.
9. Friesenecker B, Tsai AG, Allegra C, Intaglietta M. Oral administration of purified micronized flavonoid fraction suppresses leukocyte adhesion in ischemia-reperfusion injury: in vivo observations in the hamster skin fold. Int J Microcirc 1994;14:50-5.
10. Jayson MIV, Barks IS. Oedema in rheumatoid arthritis: changes in the coefficient of capillary filtration. Br Med J 1971;2:555-7.
11. Jayson MIV, Cavill I, Barks JS. Lymphatic clearance rates in rheumatoid arthritis. Ann Rheum Dis 1971;30:638-9.
12. Freemont A, Jones CJP, Bromley M, Andrews P. Changes in vascular endothelium related to lymphocyte collections in diseased synovia. Arthritis Rheum 1983;26:1427-43.
13. Schumacher HR, Kitridou RC. Synovitis of recent onset. A clinicopathologic study during the first month of disease. Arthritis Rheum 1972;15:465-85.
14. Rovenská E, Rovenská E, Neumüller I. Structure of synovial lymphatic capillaries in rheumatoid arthritis and juvenile idiopathic arthritis. Int I Tissue React 2003;25:29-38.
15. Xu H, Edwards I, Banerji S, Prevo R, Jackson DG, Athanasou NA. Distribution of lymphatic vessels in normal and arthritic human synovial tissues. Ann Rheum Dis 2003:62:1227-9.
16. Rovenská E, Štvrtina S, Greguška O, Pravda L, Rovenský J. Conspicuos synovial lymphatic capillaries in juvenile idiopathic arthritis synovitis with rice bodies. Ann Rheum Dis 2005;64:328-9.
17. Witte Ch, Witte MH, Dumont AE. Pathophysiology of chronic edema, lymphedema, and fibrosis. In: Staub NC, Taylor AE, eds. Edema. New York. Raven Press, 1984:521-42.
18. Cortas NK, Waking NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440-3.
19. Welles WL, Silkwonh J, Oronsky AL, Kerwar SS, Galivan J. Studies on the effect of low dose methotrexate in adjuvant arthritis. J Rheumatol 1985:12:904-6
20. Connolly KM, Stecher VJ, Danis E, Pruden DJ, LaBrie T. Alteration of interleukin-1 production and the acute phase response following medication or adjuvant arthritic rats with cyclosporin-A or methotrexate. Int J Immunopharmacol 1988;10:7I7-28.
21. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992;258:1898-902.
22. Oyanagui Y. Nitric oxide and superoxide radical are involved in both initiation and development of adjuvant arthritis in rats. Life Sci 1994;54:PL285-9.
23. Cannon GW, Openshaw SI, Hibbs IB It, Hoidal JR, Huecksteadt TP, Griffiths MM. Nitric oxide production during adjuvant-induced and collagen induced arthritis. Arthritis Rheum 1996,39:1677-84.
24. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA. Evans CH. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol 1995;22:1992-8.
25. Grabowski PS, England AJ, Dykhuizen R, et al. Elevated.nitric oxide production in rheumatoid arthritis detection using the fasting urinary nitrate:creatinine ratio. Arthritis Rheum 1996;39:643-7.
26. Uelki Y, Miyake S, Tominaga Y, Eguchi K. Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 1996;23:230-6.
27. Omata T, Segawa Y, Inoue N, Tsuzuike N, Itokazu Y, Tamaki H. Methotrexate suppresses nitric oxide production ex vivo in macrophages from rats with adjuvant-induced arthritis. Res Exp Med 1997;197:81-90.
28. Qlszanecki R, Gebska A, Kozlovski VI, Gryglewski RJ. Flavonoids and nitric oxide synthase. J Physiol Pharmacol 2002;53:571-84.
29. Bonnet I, Zerath E, Picaud N, et al. Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: evidence for an early bone formation defect. J Bone Miner Res 1993;8:659-68.
30. Suzuki Y, Nakagawa M, Masuda C. et al. Short term low dose methotrexate ameliorates abnormal bone metabolism and bone loss in adjuvant induced arthritis. J Rheumatol 1997,24:1890-5.
31. Kawaguchi K. Maruyama H. Kometani T, Kumazawa Y. Suppression of collagen-induced arthritis by oral administration of the citrus flavonoid hesperidin. Planta Med 2006;72:477-9.
32. Shevchuk SV, Stanislavchuk MA, Pentiuk OO. Efficacy and safety of treatment with methotrexate, leflunomide, detralex, and their combination of patients with rheumatoid arthritis. Lik Sprava 2003;3-4:34-41.